Hofland J - Search Results

1

In touch with your feminine side: how oestrogen metabolism impacts prostate cancer.

Rahman HP, Hofland J, Foster PA. Rahman HP, et al. Among authors: hofland j. Endocr Relat Cancer. 2016 Jun;23(6):R249-66. doi: 10.1530/ERC-16-0118. Epub 2016 May 18. Endocr Relat Cancer. 2016. PMID: 27194038 Review.

2

Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesis.

Kumagai J, Hofland J, Erkens-Schulze S, Dits NF, Steenbergen J, Jenster G, Homma Y, de Jong FH, van Weerden WM. Kumagai J, et al. Among authors: hofland j. Prostate. 2013 Nov;73(15):1636-50. doi: 10.1002/pros.22655. Epub 2013 Sep 2. Prostate. 2013. PMID: 23996639

3

Circulating steroid hormone variations throughout different stages of prostate cancer.

Snaterse G, Visser JA, Arlt W, Hofland J. Snaterse G, et al. Among authors: hofland j. Endocr Relat Cancer. 2017 Nov;24(11):R403-R420. doi: 10.1530/ERC-17-0155. Epub 2017 Sep 18. Endocr Relat Cancer. 2017. PMID: 28924064 Review.

4

Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer.

Hofland J, van Weerden WM, Dits NF, Steenbergen J, van Leenders GJ, Jenster G, Schröder FH, de Jong FH. Hofland J, et al. Cancer Res. 2010 Feb 1;70(3):1256-64. doi: 10.1158/0008-5472.CAN-09-2092. Epub 2010 Jan 19. Cancer Res. 2010. PMID: 20086173

5

Activin A stimulates AKR1C3 expression and growth in human prostate cancer.

Hofland J, van Weerden WM, Steenbergen J, Dits NF, Jenster G, de Jong FH. Hofland J, et al. Endocrinology. 2012 Dec;153(12):5726-34. doi: 10.1210/en.2011-2065. Epub 2012 Sep 28. Endocrinology. 2012. PMID: 23024260

6

Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane.

van Koetsveld PM, Vitale G, Feelders RA, Waaijers M, Sprij-Mooij DM, de Krijger RR, Speel EJ, Hofland J, Lamberts SW, de Herder WW, Hofland LJ. van Koetsveld PM, et al. Among authors: hofland j, hofland lj. Endocr Relat Cancer. 2013 May 30;20(3):443-54. doi: 10.1530/ERC-12-0217. Print 2013 Jun. Endocr Relat Cancer. 2013. PMID: 23507702

7

11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration.

Snaterse G, van Dessel LF, van Riet J, Taylor AE, van der Vlugt-Daane M, Hamberg P, de Wit R, Visser JA, Arlt W, Lolkema MP, Hofland J. Snaterse G, et al. Among authors: hofland j. JCI Insight. 2021 Jun 8;6(11):e148507. doi: 10.1172/jci.insight.148507. JCI Insight. 2021. PMID: 33974560 Free PMC article.

8

Predicting symptomatic mesenteric mass in small intestinal neuroendocrine tumors using radiomics.

Blazevic A, Starmans MPA, Brabander T, Dwarkasing RS, van Gils RAH, Hofland J, Franssen GJH, Feelders RA, Niessen WJ, Klein S, de Herder WW. Blazevic A, et al. Among authors: hofland j. Endocr Relat Cancer. 2021 Jun 21;28(8):529-539. doi: 10.1530/ERC-21-0064. Endocr Relat Cancer. 2021. PMID: 34003139

9

Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.

Moll JM, Hofland J, Teubel WJ, de Ridder CMA, Taylor AE, Graeser R, Arlt W, Jenster GW, van Weerden WM. Moll JM, et al. Among authors: hofland j. Prostate. 2022 Apr;82(5):505-516. doi: 10.1002/pros.24297. Epub 2022 Jan 17. Prostate. 2022. PMID: 35037287 Free PMC article.

10

The role of 11-oxygenated androgens in prostate cancer.

Snaterse G, Hofland J, Lapauw B. Snaterse G, et al. Among authors: hofland j. Endocr Oncol. 2023 Mar 13;3(1):e220072. doi: 10.1530/EO-22-0072. eCollection 2023 Jan 1. Endocr Oncol. 2023. PMID: 37434644 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

521 results

Search Page